SEGMENT INFORMATION

12 Months Ended

Mar. 31, 2012

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product categories.

Enterprise Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include equipment devices and the related disposables used with these devices. Disposables include the plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals (also known as source plasma). Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients. Hospital consists of surgical disposables (principally the Cell Saver^® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT^® cardiovascular perioperative autotransfusion system designed to remain with the patient following surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s hemostasis (blood clotting ability) during and after surgery).

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

(In thousands)	March 31, 2012		April 2, 2011		April 3, 2010
Disposable revenues
Plasma disposables	$	258,061	$	227,209	$	232,378
Blood center disposables
Platelet	167,946		156,251		151,026
Red cell	48,034		46,828		48,031
	215,980		203,079		199,057
Hospital disposables
Surgical	66,619		66,503		69,942
OrthoPAT	31,186		35,631		37,079
Diagnostics	23,087		19,414		16,770
	120,892		121,548		123,791
Disposables revenue	594,933		551,836		555,226
Software solutions	70,557		66,876		35,919
Equipment & other	62,354		57,982		54,285
Total revenues	$	727,844	$	676,694	$	645,430

Enterprise Wide Disclosures about Product and Services

Year ended (in thousands)

March 31, 2012	United States		Other North America		Total North America		Japan		Other Asia		Total Asia		Total Europe		Total Consolidated
Sales	$	352,160	$	512	$	352,672	$	124,381	$	67,223	$	191,604	$	183,568	$	727,844
Total Assets	$	634,171	$	15,365	$	649,536	$	50,509	$	27,353	$	77,862	$	183,737	$	911,135
Long-Lived Assets	$	305,370	$	12,796	$	318,166	$	13,128	$	3,961	$	17,089	$	38,009	$	373,264

April 2, 2011	United States		Other North America		Total North America		Japan		Other Asia		Total Asia		Total Europe		Total Consolidated
Sales	$	316,447	$	908	$	317,355	$	110,263	$	61,594	$	171,857	$	187,482	$	676,694
Total Assets	$	582,733	$	15,903	$	598,636	$	47,156	$	18,164	$	65,320	$	169,308	$	833,264
Long-Lived Assets	$	305,305	$	12,715	$	318,020	$	12,391	$	4,181	$	16,572	$	38,092	$	372,684

April 3, 2010	United States		Other North America		Total North America		Japan		Other Asia		Total Asia		Total Europe		Total Consolidated
Sales	$	301,774	$	2,191	$	303,965	$	109,573	$	51,324	$	160,897	$	180,568	$	645,430
Total Assets	$	487,955	$	22,941	$	510,896	$	42,438	$	20,928	$	63,366	$	190,043	$	764,305
Long-Lived Assets	$	313,241	$	16,800	$	330,041	$	11,230	$	3,805	$	15,035	$	19,285	$	364,361

The Long-Lived Assets reported above include Goodwill, Other Intangibles and Net Property, Plant and Equipment.